ea0056gp176 | Parathyroid | ECE2018
Chen Kristina
, Hadker Nandini
, Abibova Irana
, Hanbury-Brown Lachlan
, Vera-Llonch Montserrat
, Clarke Bart
Chronic hypoparathyroidism (HypoPT) is a rare disease associated with a variety of symptoms and diminished health-related quality of life (HRQoL). This study aimed to characterise and quantify the symptom burden, HRQoL, and overall disease impact in patients receiving recombinant human parathyroid hormone (rhPTH1-84, Natpar®) for inadequately controlled HypoPT and in symptomatic patients receiving standard therapy (ST; calcium and/or vitamin D supplements). A w...